Descrizione

DNA sequencing is a laboratory technique used to determine the exact sequence of bases (UN, C, G, and T) in a DNA molecule. The DNA base sequence carries the information a cell needs to assemble protein and RNA molecules. DNA sequence information is important to scientists investigating the functions of genes. The global dna sequencing market is set to grow by US$ 22 miliardi durante 2021-2027, crescendo ad un tasso di crescita annuale composto (CAGR) Di 17.6% durante il periodo di previsione, secondo la società di dati e analisi StrategyHelix.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2017-2020 e previsione a 2027 covering key market aspects like sales value for dna sequencing. The global dna sequencing market is segmented on the basis of product, sequencing type, utente finale, e regione. Per prodotto, it is categorized into sequencing services, sequencing instruments, sequencing consumables, and sequencing informatics. The sequencing services segment held the largest market share in 2020. Tuttavia, the sequencing informatics segment is expected to witness the highest CAGR during the forecast period. By sequencing type, the dna sequencing market is divided into next generation sequencing (NGS), sanger sequencing, e altri. The NGS segment accounted for the largest market share in 2020. Based on end user, the dna sequencing market is divided into hospitals & healthcare organizations, accademici & research institutions, enterprises, e altri.

The report has profiled some of the key players of the market such as Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eurofins Scientific Inc., F. Hoffmann-La Roche AG, Illumina Inc., Merck KGaA, Pacific Biosciences of California Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., BGI Group, QIAGEN N.V..

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the dna sequencing market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Prodotto: sequencing services, sequencing instruments, sequencing consumables, and sequencing informatics
Sequencing type: next generation sequencing (NGS), sanger sequencing, e altri
Utente finale: ospedali & healthcare organizations, accademici & research institutions, enterprises, e altri
Regione: Nord America, Asia Pacifico, Europa, and Rest of the World (RIGA)
Anni considerati: la presente relazione copre il periodo 2017 A 2027

Principali vantaggi per gli stakeholder

Get a comprehensive picture of the global dna sequencing market
Identificare le strategie regionali e le priorità strategiche sulla base di dati e analisi locali
Individuare i settori in crescita e le tendenze per gli investimenti
Understand what the future of the global dna sequencing market looks like
Identificare il panorama competitivo e la finestra di opportunità

Sommario

1. Definizione del mercato
2. Metodologia di ricerca
3. Dati di mercato & Veduta
3.1 Valore di mercato
3.2 Previsione del valore di mercato
4. DNA Sequencing Market by Product
4.1 Sequencing Services
4.2 Sequencing Instruments
4.3 Sequencing Consumables
4.4 Sequencing Informatics
5. DNA Sequencing Market by Sequencing Type
5.1 Next Generation Sequencing (Ngs)
5.2 Sanger Sequencing
5.3 Altri
6. DNA Sequencing Market by End User
6.1 Ospedali & Healthcare Organizations
6.2 Academics & Research Institutions
6.3 Enterprises
6.4 Altri
7. DNA Sequencing Market by Region
7.1 Nord America
7.2 Asia Pacifico
7.3 Europa
7.4 Rest Of The World (Row)
8. Profili aziendali
8.1 Agilent Technologies Inc.
8.2 Bio-Rad Laboratories Inc.
8.3 Danaher Corporation
8.4 Eurofins Scientific, Inc.
8.5 F. Hoffmann-La Roche AG
8.6 Illumina Inc.
8.7 Merck KGaA
8.8 Pacific Biosciences of California Inc.
8.9 PerkinElmer Inc.
8.10 Thermo Fisher Scientific Inc.
8.11 BGI Group
8.12 QIAGEN N.V.
9. Appendice
9.1 Informazioni su StrategyHelix
9.2 Disclaimer